Kimber Simmons

16PUBLICATIONS
93CO-AUTHORS
Gene and molecular therapyPacific Peoples theory of change models for healthInfant and child healthAboriginal and Torres Strait Islander youth and family social and emotional wellbeingPreventative health care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Nov 11, 2026
Clinical Guidance for Disease-Modifying Immunotherapy in Children and Adolescents With New-Onset (Stage 3) Type 1 Diabetes.

|Sep 10, 2026
Preserving beta cell function in children and adolescents with newly diagnosed stage 3 type 1 diabetes: per-protocol population analysis from the PROTECT randomised trial.

|Jan 14, 2026
Teplizumab treatment for stage 2 type 1 diabetes: a real-world evaluation of metabolic and immunological outcomes.

Kagan E Karakus, Lexie Chesshir, Sonya Walker

|Nov 06, 2025
Safety and pharmacokinetics of teplizumab in children less than 8 years of age with stage 2 type 1 diabetes.

Stephen E Gitelman, Kimber Simmons, Jennifer L Sherr

|Oct 27, 2025
Children's Understanding of Risk for Type 1 Diabetes: The TEDDY Study.

Holly O'Donnell, Roy Tamura, Laura Smith

|Feb 14, 2025
Real-world experiences of adult individuals or caregivers of children who received teplizumab treatment in stage 2 type 1 diabetes.

Holly K O'Donnell, Kimber M Simmons, Stephen E Gitelman

Pageof 3

Frequent Collaborators

6 joint publications

Linda A DiMeglio

6 joint publications

Holly O'Donnell

5 joint publications

Stephen Gitelman

5 joint publications

Andrea K Steck